Allergy Therapeutics plc
Block Listing Interim Review
Date2 August 2022
Name of applicant: |
ALLERGY THERAPEUTICS PLC |
|||
Name of scheme: |
Allergy Therapeutics plc 2013 Long Term Incentive Plan |
|||
Period of return: |
From: |
1 February 2022 |
To: |
31 July 2022 |
Number and class of share(s) (amount of stock / debt securities) originally listed and the date of admission: |
10,000,000 ordinary shares of 0.1p each in the Company admitted to trading on 24 November 2017 |
|||
Balance of unallotted securities under scheme(s) from previous return: |
7,118,772 |
|||
Plus:The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
Less:Number of securities issued/allotted under scheme(s) during period: |
0 |
|||
Equals:Balance under scheme(s) not yet issued/allotted at end of period: |
7,118,772 |
|||
Name of contact: |
Sara Goldsbrough |
Telephone number of contact: |
+44 (0) 7966 165719 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. ENDBLREAFPAESKAEFA You are subscribed to notifications from Allergy Therapeutics Investor Relations e-mail notifications with the email .
Allergy Therapeutics
This service is provided by Q4 Inc.